How an Aging Immune System May Accelerate Aging Across the Body

The immune system may do more than grow old alongside the rest of the body. In mice, damaged immune cells can transmit age-related changes to organs that were never directly altered.

Aging pushes immunity in two opposing directions. Responses to unfamiliar infections and vaccination become weaker, while persistent low-grade inflammation continues even when there is no obvious threat. This broader remodeling is known as immune aging, or immunosenescence.

A review in Nature Reviews Immunology brings together evidence from almost 200 publications involving humans and mice. It is not a clinical study with one cohort, one control group or a defined follow-up period. There is no single sample size or pooled estimate. Instead, the authors compare findings across experiments and observational studies to ask whether an aging immune system is merely a consequence of aging or one of its active drivers.

What changes inside the immune system

Part of the shift begins in the bone marrow, where blood cells are produced. Aging hematopoietic stem cells increasingly favor myeloid cells, which are closely involved in innate immunity and inflammation, while generating fewer new T and B lymphocytes. The pool of naïve lymphocytes—cells that have not yet encountered a particular pathogen and can respond to a new threat—also contracts.

Immune cells accumulate DNA damage, mitochondrial defects and changes in gene regulation. Some become exhausted and lose part of their normal function. Others enter cellular senescence: they stop dividing but remain metabolically active and release signaling molecules that sustain inflammation.

This creates a feedback loop. Damaged tissues activate immune cells, while aged immune cells release inflammatory signals, clear defective cells less efficiently and contribute to further tissue damage. Age-related inflammation therefore becomes more than a local reaction. It can connect dysfunction across organs.

When immune cells carried aging into other tissues

The strongest causal evidence still comes from mouse experiments. In one central study, researchers disabled the DNA-repair gene Ercc1 only in blood-forming cells. The animals developed normally, but by 8–10 months their immune systems displayed changes resembling those seen in much older, roughly two-year-old mice.

The effects were not confined to blood, spleen or bone marrow. Markers of cellular senescence, oxidative damage and disrupted tissue homeostasis increased in the liver, kidneys, lungs and other tissues.

Researchers then transferred spleen cells from these animals, or from naturally old mice, into young recipients aged 3–4 months. Senescence-related markers rose in several recipient tissues. The reverse experiment produced a partial improvement: transferring young immune cells into old animals reduced some signs of cellular senescence and organ damage.

These experiments show that aged immune cells can actively induce changes outside the immune system. They do not establish that normal human aging follows the same sequence, or that immune dysfunction is its dominant cause.

Treatment remains an open question

The review discusses several ways in which aging immunity might be supported: exercise and calorie restriction, blockade of selected inflammatory pathways, removal of senescent cells, manipulation of blood-forming stem cells and partial cellular reprogramming. Some approaches have produced benefits in animals, and a smaller body of human research has reported changes in immune-related measures.

There is no established treatment that rejuvenates the human immune system and thereby slows aging throughout the body. The review spans different species, cell types and disease settings, while the clearest causal evidence comes from genetically modified mice and small cell-transfer experiments.

Aging increasingly looks less like the independent deterioration of separate organs and more like a failure of communication between cells and tissues. The immune system is one of the main messengers capable of spreading the consequences of that failure across the body.